News & Events
Stay up-to-date with news covering CAR T-cell therapy, biotech and immunotherapy.
Hear how we are supporting cancer patients, partners and our global community through cutting edge technology and automated, closed loop manufacturing of CAR T-cell therapies.
BioOra scaling up manufacturing to support the Malaghan Institute’s phase 2 trial to register CD19-specific CAR T
BioOra is excited to announce that manufacturing is scaling up to support the registration of WZTL-002 for commercialisation.
John Robson appointed Managing Director of BioOra
We're thrilled to announce that John Robson (JR) has been appointed as our new Managing Director.
‘Game changing’ economy boost from cancer treatment company
BioOra is excited to announce that in collaboration with Christchurch NZ, BioOra has committed to the installation of a innovative cell therapy manufacturing site in Christchurch
Significant milestone in first NZ CAR T-cell trial: preparations for larger Phase 2 registration trial
Enrolment and treatment is now complete. BioOra provided outpatient management and automated CAR T-cell manufacturing for patients in dose expansion cohort.
ASH presentation
ENABLE Phase 1 data support BioOra’s automated manufacture for Phase 2 trial
Carl June joins BioOra Board
Globally recognised pioneer of CAR T-cell therapy appointed to the Board of Directors
Manufacturing milestone
Malaghan Institute and BioOra deliver automated manufacturing to scale up CAR T-cell cancer therapy in NZ
Meet us @ the ISCT Australia & New Zealand
Meet Andi (CEO) and Alex (Head of Operations) in Perth.
RNZ: New Zealand developed cancer treatment one step closer to market
Clinical Director Dr Rob Weinkove about our CAR T-cell clinical trial.
Meet Us @ the Life Science Summit NZ
Challenges and Opportunities of Cell and Gene Therapy in NZ.
RE-TELL: telling the patient side of
CAR T-cell cancer therapy
Giving a voice to New Zealand patients undergoing CAR T-cell therapy is an important part of the Malaghan Institute’s ...
In Focus: Transforming our immune cells into cancer killers
“I look forward to when CAR T-cell therapy can be administered to people as a standard of care rather than a last resort."
Improving CAR T-cell therapy to target solid tumors
Much still stands in the way of CAR T-cell therapy becoming an effective treatment option.
Our Changing World - the future of cancer treatment
Our CAR T-cell research team talks to Claire Concannon from RNZ's...
In focus: Overcoming hurdles facing CAR T-cell therapy
Researching ways to fight cancer is not a job for the faint-hearted.
New partnership to scale up
CAR T-cell cancer treatment in New Zealand
Malaghan Institute of Medical Research
Building better CAR T-cell technology
With the astronomical success of CAR T-cell therapy, it’s hard to believe that this groundbreaking cancer treatment is still in its infancy.
CAR T-cell supporter David Downs semi-finalist for New Zealander of the Year
David discovered that the Malaghan Institute was preparing to conduct its own CAR T-cell clinical trial.